# Pitney Bowes Inc: overview

PBI · NYSE · CIK 78814 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pbi.md) · [Financials](/companies/pbi/financials.md) · [Filings](/companies/pbi/filings.md) · [Insiders](/companies/pbi/insiders.md)

Latest reported revenue: [$456.2m](/filings/0001628280-26-068089.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:Revenues, accession 0001628280-26-068089).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [516](/filings/0000078814-25-000015.md) | [493](/filings/0001628280-26-031003.md) | [462](/filings/0001628280-26-050908.md) | [460](/filings/0001628280-26-068089.md) | [478 d](/filings/0001628280-26-009921.md) | [477](/filings/0001628280-26-031003.md) | [451](/filings/0001628280-26-050908.md) | [456](/filings/0001628280-26-068089.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(7.2%)](/filings/0000078814-25-000015.md) | [7.2%](/filings/0001628280-26-031003.md) | [6.5%](/filings/0001628280-26-050908.md) | [11.3%](/filings/0001628280-26-068089.md) | [5.7% d](/filings/0001628280-26-009921.md) | [12.2%](/filings/0001628280-26-031003.md) | [11.1%](/filings/0001628280-26-050908.md) | [11.5%](/filings/0001628280-26-068089.md) |
| Diluted EPS | $ per share | [(0.21)](/filings/0000078814-25-000015.md) | [0.19](/filings/0001628280-26-031003.md) | [0.17](/filings/0001628280-26-050908.md) | [0.30](/filings/0001628280-26-068089.md) | not reported | [0.39](/filings/0001628280-26-031003.md) | [0.36](/filings/0001628280-26-050908.md) | [0.37](/filings/0001628280-26-068089.md) |
| Free cash flow | $m | [112 d](/filings/0001628280-26-009921.md) | [(33.6)](/filings/0001628280-26-031003.md) | [98.0 d](/filings/0001628280-26-050908.md) | [51.1 d](/filings/0001628280-26-068089.md) | [201 d](/filings/0001628280-26-009921.md) | [28.3](/filings/0001628280-26-031003.md) | [134 d](/filings/0001628280-26-050908.md) | [140 d](/filings/0001628280-26-068089.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,674](/filings/0000078814-24-000004.md) | [2,483](/filings/0000078814-25-000015.md) | [2,079](/filings/0001628280-26-009921.md) | [2,027](/filings/0001628280-26-009921.md) | [1,893](/filings/0001628280-26-009921.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [(0.0%)](/filings/0000078814-24-000004.md) | [1.5%](/filings/0000078814-25-000015.md) | [(18.5%)](/filings/0001628280-26-009921.md) | [(10.0%)](/filings/0001628280-26-009921.md) | [7.6%](/filings/0001628280-26-009921.md) |
| Diluted EPS | $ per share | [(0.01)](/filings/0000078814-24-000004.md) | [0.21](/filings/0000078814-25-000015.md) | [(2.20)](/filings/0001628280-26-009921.md) | [(1.12)](/filings/0001628280-26-009921.md) | [0.84](/filings/0001628280-26-009921.md) |
| Free cash flow | $m | [117](/filings/0000078814-23-000012.md) | [92.4](/filings/0000078814-25-000015.md) | [2.0](/filings/0001628280-26-009921.md) | [157](/filings/0001628280-26-009921.md) | [317](/filings/0001628280-26-009921.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pbi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $220.5m | 12,584,067 |  | Reduced −2,089,794 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $135.1m | 7,709,733 |  | Reduced −688,838 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $107.8m | 6,152,596 |  | Reduced −264,876 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $95.2m | 5,433,609 |  | Reduced −626,017 |
| [D. E. Shaw & Co., Inc.](/funds/1009207.md) | 2026-06-30 | $66.8m | 3,812,173 |  | Added +1,711,472 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $61.7m | 3,523,736 |  | Reduced −234,387 |
| [Permit Capital, LLC](/funds/1313978.md) | 2026-06-30 | $61.3m | 3,500,000 |  | Unchanged |
| [Hestia Capital Management, LLC](/funds/1815344.md) | 2026-06-30 | $59.6m | 3,403,420 |  | Reduced −4,752,385 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $52.4m | 2,991,475 |  | Reduced −204,329 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $50.4m | 2,878,301 |  | Added +2,313,480 |

## Recent filings

[All 1,430 filings](/companies/pbi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 11:16 ET | [10-Q](/filings/0001628280-26-068089.md) | Quarterly report, period 2026-09-30 | 0001628280-26-068089 |
| 2026-10-28 | 16:09 ET | [8-K](/filings/0001628280-26-067888.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-067888 |
| 2026-09-30 | 08:08 ET | [8-K](/filings/0001193125-26-408361.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-408361 |
| 2026-09-21 | 09:53 ET | [8-K](/filings/0001628280-26-062820.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-062820 |
| 2026-08-20 | 07:10 ET | [8-K](/filings/0001628280-26-058130.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-058130 |
| 2026-07-30 | 11:30 ET | [10-Q](/filings/0001628280-26-050908.md) | Quarterly report, period 2026-06-30 | 0001628280-26-050908 |
| 2026-07-29 | 16:09 ET | [8-K](/filings/0001628280-26-050614.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-050614 |
| 2026-07-27 | 08:05 ET | [8-K](/filings/0001628280-26-049667.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-049667 |
| 2026-06-25 | 08:12 ET | [8-K](/filings/0001193125-26-281893.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-281893 |
| 2026-05-19 | 08:24 ET | [8-K](/filings/0001628280-26-036154.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-036154 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-009650.md), filed Feb 19, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/21e15804-6f58-46f7-bb2f-53e83cff175b)

## About the filer

- CIK: 78814
- Tickers: PBI, PBI-PB
- Exchange: NYSE
- SIC code: 3579 Office Machines, NEC
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 31, 2026, 14:06 ET. No prices; not investment advice.